Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.

New AI-assisted development approach reduces costs and accelerates delivery timelines for modern JavaScript applications ...

Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its artificial intelligence offerings and Nvidia ...

The new Anaconda AI Catalyst development tool suite includes a catalog of vetted open-source AI models that the company says help bridge the gap between the need for rapid AI application development ...

AI Impact examines the race to deploy AI before governance can catch up, plus clinical use cases, risks and leadership moves.

Artificial intelligence is rapidly reshaping the way software is built, but its impact is more nuanced than many ...

Checkmarx today unveiled Checkmarx One, an AppSec platform that embeds agentic, AI-driven security across code, dependencies, AI assets and runtime.

But there’s a difference between raw speed and real velocity. Raw speed is how fast you do things. It doesn’t matter what ...

Corridor, the security platform built for AI-native software development, has raised a $25 million Series A at a $200 million valuation, led by Felicis, with participation from Conviction, Timeless, ...

Razer QA Companion AI aims to reduce the manual workload involved in game testing. The tool can detect bugs from gameplay footage and automatically generate detailed reports. Developers can generate ...

SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...